Across TCGA pan-cancer cohorts, LINC01509 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01509’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC01509 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01509 is over-expressed in tumor.

LIHC and PRAD are the cancer types where LINC01509 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01509 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.148	<.001	8	view →
PRAD	All	All	+1.610	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC01509 RNA expression & survival · all LINC01509 data types